Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-22-124873
Filing Date
2022-12-06
Accepted
2022-12-06 16:06:17
Documents
7
Effectiveness Date
2022-12-06

Document Format Files

Seq Description Document Type Size
1 POSASR tm2231831-1_s3asr.htm POSASR 232427
2 EXHIBIT 5.1 tm2231831d2_ex5-1.htm EX-5.1 5392
3 EXHIBIT23.1 tm2231831d2_ex23-1.htm EX-23.1 2497
4 EX-FILING FEES tm2231831d2_ex-filingfees.htm EX-FILING FEES 26458
5 GRAPHIC tm2231831d2_ex5-1img001.jpg GRAPHIC 16906
6 GRAPHIC tm2231831d2_ex5-1img002.jpg GRAPHIC 23144
7 GRAPHIC lg_nateracondel-4c.jpg GRAPHIC 59023
  Complete submission text file 0001104659-22-124873.txt   404747
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-259429 | Film No.: 221447696
SIC: 8071 Services-Medical Laboratories